Phibro Animal Health
PAHC | NASDAQ
$35.02
-$0.95 (-2.64%)
At close: Nov 16, 2026, 4:00 PM ET
$35.02
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:15 PM ET
Phibro Animal Health Company Profile
Company profile explainedCompany Profile
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.
Key Executives
| Name | Position |
|---|---|
| Daniel Bendheim | CEO, President & Director |
| Glenn C. David | Chief Financial Officer |
| Larry L. Miller | Chief Operating Officer |
| Jack Clifford Bendheim | Executive Chairman |
| Jonathan Bendheim | Executive VP of Talent, Technology and Business Development & Director |
| Judith A. Weinstein | Senior Vice President, General Counsel & Corporate Secretary |
| Lisa A. Escudero | Senior Vice President of Human Resources |
| Michael Giambalvo | President of PhibroChem and Ethanol Performance Group |
| Mona Desai | Vice President & Corporate Controller |
| Ramon Fuenmayor | President South America Region |
| Samson Li | President of Asia Pacific Region |
| Todd Armstrong | President of North American Region |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 19, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Sep 18, 2026 | ARS | Filing |
| Sep 18, 2026 | DEFA14A | Filing |
| Sep 18, 2026 | DEF 14A | Filing |
| Sep 17, 2026 | 4/A | [Amend] Filing |
| Sep 17, 2026 | 4/A | [Amend] Filing |
| Aug 26, 2026 | 8-K | Current Report |
| Aug 26, 2026 | 10-K | Annual Report |
| Aug 10, 2026 | 4 | Filing |
| Aug 10, 2026 | 4 | Filing |
Phibro Animal Health
| Country | United States |
| IPO Date | Apr 11, 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,605 |
| CEO | Daniel Bendheim |
Contact Details
Glenpointe Centre East Teaneck,
New Jersey 07666-6712 United States
Stock Details
| Ticker Symbol | PAHC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001069899 |
| CUSIP Number | 71742Q106 |
| ISIN Number | US71742Q1067 |
| SIC Code | 2834 |
Recent News
- 10 days ago / seekingalpha.comPhibro Animal Health Corporation (PAHC) Q1 2027 Earnings Call Transcript
- 12 days ago / zacks.comPhibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say
- 12 days ago / businesswire.comPhibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance
- 13 days ago / businesswire.comPhibro Animal Health Corporation Declares Quarterly Dividend
- 19 days ago / businesswire.comPhibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
- 25 days ago / zacks.comWill Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?
- 27 days ago / zacks.comPAHC or SYK: Which Is the Better Value Stock Right Now?
- 1 month ago / zacks.comPAHC vs. HAE: Which Stock Is the Better Value Option?
- 2 months ago / zacks.comBest Momentum Stocks to Buy for September 21st
- 2 months ago / zacks.comPAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Add to Watchlist
Select watchlists to add or remove PAHC